To win the battle against coronavirus, a pharmaceutical company in central China’s Hunan province has donated a large sum of a traditional Chinese medicine (TCM) that treats bronchitis to Afghanistan, Pakistan and Iran, Ecns.cn reported on Monday.
The drug passed the clinical trial in Pakistan and proved effective for Pakistani patients in 2019.
The medicine, Yinhuang Qingfei Capsule, has been listed as a recommended TCM in the treatment plan for the COVID-19 by the provincial TCM regulator in Hunan.
A shipment of 1,500 boxes of the capsule, manufactured and donated by Hunan Anbang Pharmaceutical Co. Ltd., is on its way to Urumqi, capital city of Xinjiang Uygur Autonomous Region, and will be sent to the Afghan capital of Kabul on March 25 via air.
Previously, Anbang sent 1,500 boxes of the drug to Pakistan and 3,600 boxes to Iran to aid their fight against the COVID-19.
